Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | Jun 27, 2018 at 11:55 AM EDT

How a New Gout Drug Could Lead to 100% to 200% Upside

Janney Montgomery Scott has initiated coverage of Selecta Biosciences with a price target that represents huge upside.

Chris Lange | Jun 27, 2018 at 11:45 AM EDT

Cara Therapeutics Wins Big With Abdominal Pain Trial

Cara Therapeutics shares made a solid gain on Wednesday after the biotech announced positive results from a midstage trial.

Chris Lange | Jun 27, 2018 at 10:35 AM EDT

Why Summit Therapeutics Was Crushed

Summit Therapeutics is another biopharma company that is paying the price on Wednesday.

Chris Lange | Jun 27, 2018 at 10:20 AM EDT

Is Aquinox Pharmaceuticals Done?

Aquinox Pharmaceuticals saw its shares crash on Wednesday after the firm gave a disappointing update for a late-stage trial.

Chris Lange | Jun 27, 2018 at 9:00 AM EDT

Short Sellers Run for Cover From Major Biotechs

The June 15 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jun 26, 2018 at 11:35 AM EDT

Can Puma Biotechnology Break In to Europe?

Puma Biotechnology shares were climbing on Tuesday after the company announced that it expects a positive outcome in Europe.

Chris Lange | Jun 26, 2018 at 11:05 AM EDT

Achaogen Receives Mixed Update From FDA

Achaogen shares were crumbling on Tuesday following some mixed news from the FDA regarding its treatment of urinary tract and…

Chris Lange | Jun 26, 2018 at 10:25 AM EDT

Is This the Turnaround That Achieve Life Sciences Has Waited For?

Achieve Life Sciences saw its shares skyrocket on Tuesday after the company announced positive results from its smoking cessation study.

Chris Lange | Jun 26, 2018 at 10:15 AM EDT

Why Infinity Pharma Shares Are Booming

Infinity Pharmaceuticals shares made a healthy gain early on Tuesday after the firm announced a clinical collaboration with Arcus Biosciences.

Jon C. Ogg | Jun 26, 2018 at 9:15 AM EDT

General Electric Moves Closer to Outright Breakup

GE has completed its strategic review and announced the conglomerate's path forward, including spinning off its health care unit.

Paul Ausick | Jun 25, 2018 at 2:00 PM EDT

Epilepsy Treatment Derived From Marijuana Approved for US Sales

GW Pharmaceuticals on Monday received approval from the U.S. FDA for its epilepsy drug derived from the marijuana plant. This…

Chris Lange | Jun 25, 2018 at 10:05 AM EDT

Why Merrimack Pharmaceuticals Is Getting Crushed

Merrimack Pharmaceuticals shares were absolutely getting crushed on Monday after the firm gave an update from its midstage pancreatic cancer…

Chris Lange | Jun 25, 2018 at 9:00 AM EDT

Positive Late-Stage Trial Not Enough to Move the Needle for Pfizer

Pfizer shares slipped slightly on Monday morning after the firm announced results from its late-stage trial of breast cancer. Ultimately…

Chris Lange | Jun 24, 2018 at 10:15 AM EDT

Biopharma Companies to Watch This Week

Here, 24/7 Wall St. has included a calendar of a few of companies to watch for in the coming week…

Chris Lange | Jun 22, 2018 at 10:35 AM EDT

Tandem Diabetes Keeps Rolling Out the Hits

Tandem Diabetes Care shares made a solid gain early on Friday after the firm announced a key approval from the…

1 … 128 129 130 131 132 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

How a New Gout Drug Could Lead to 100% to 200% Upside

Cara Therapeutics Wins Big With Abdominal Pain Trial

Why Summit Therapeutics Was Crushed

Is Aquinox Pharmaceuticals Done?

Short Sellers Run for Cover From Major Biotechs

Can Puma Biotechnology Break In to Europe?

Achaogen Receives Mixed Update From FDA

Is This the Turnaround That Achieve Life Sciences Has Waited For?

Why Infinity Pharma Shares Are Booming

General Electric Moves Closer to Outright Breakup

Epilepsy Treatment Derived From Marijuana Approved for US Sales

Why Merrimack Pharmaceuticals Is Getting Crushed

Positive Late-Stage Trial Not Enough to Move the Needle for Pfizer

Biopharma Companies to Watch This Week

Tandem Diabetes Keeps Rolling Out the Hits

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Health and Healthcare Articles

All Health and Healthcare Articles

How a New Gout Drug Could Lead to 100% to 200% Upside

Cara Therapeutics Wins Big With Abdominal Pain Trial

Why Summit Therapeutics Was Crushed

Is Aquinox Pharmaceuticals Done?

Short Sellers Run for Cover From Major Biotechs

Can Puma Biotechnology Break In to Europe?

Achaogen Receives Mixed Update From FDA

Is This the Turnaround That Achieve Life Sciences Has Waited For?

Why Infinity Pharma Shares Are Booming

General Electric Moves Closer to Outright Breakup

Epilepsy Treatment Derived From Marijuana Approved for US Sales

Why Merrimack Pharmaceuticals Is Getting Crushed

Positive Late-Stage Trial Not Enough to Move the Needle for Pfizer

Biopharma Companies to Watch This Week

Tandem Diabetes Keeps Rolling Out the Hits

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how